Moderna | MRNA - Deudores Comerciales





Deudores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.14B 432M 2026-03
Arrowhead Research USD 15.68M 203.19M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Celltrion KRW 2.05T 542.39B 2025-12
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Moderna USD 71M 113M 2026-03
Organigram Holdings CAD 49.94M 14.92M 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pharma Mar EUR 51.19M 9.4M 2026-03
Puma Biotechnology USD 28.1M 3.52M 2024-06
Qiagen NV USD 402.61M 9.05M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Tilray USD 109.07M 2M 2025-09
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03